Basic Information
ID: ALA3536182
Type: ADME
Description: Drug metabolism in human liver S9 fraction treated with 50 uM of lenvatinib up to 120 mins by HPLC analysis in presence of GSH and NADPH
Format: BAO_0000220
Organism: Homo sapiens
Tissue: Liver
Subcellular Fraction: Liver S9 fraction
Target: ADMET(ALA612558)
Document: ALA3526157
Drug metabolism in human liver S9 fraction treated with 50 uM of lenvatinib up to 120 mins by HPLC analysis in presence of GSH and NADPH: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3536182
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 507.53 | -0.69 | -0.69 |